A. Le Cesne

1.0k total citations
41 papers, 369 citations indexed

About

A. Le Cesne is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, A. Le Cesne has authored 41 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 19 papers in Gastroenterology and 9 papers in Surgery. Recurrent topics in A. Le Cesne's work include Sarcoma Diagnosis and Treatment (29 papers), Gastrointestinal Tumor Research and Treatment (19 papers) and Gastric Cancer Management and Outcomes (8 papers). A. Le Cesne is often cited by papers focused on Sarcoma Diagnosis and Treatment (29 papers), Gastrointestinal Tumor Research and Treatment (19 papers) and Gastric Cancer Management and Outcomes (8 papers). A. Le Cesne collaborates with scholars based in France, Belgium and Australia. A. Le Cesne's co-authors include Karim Fizazi, M. Spielmann, J.P. Delord, Laurent Zelek, O. Rixe, M. Riofrio, Jean‐Yves Blay, Sylvie Bonvalot, D. Vanel and C. Le Péchoux and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

A. Le Cesne

38 papers receiving 362 citations

Peers

A. Le Cesne

PRM

ONCOL

GASTR

SURGE

Bart Rikhof Netherlands

Jacek Sygut Poland

P. Chalabreysse France

C. Piovesan Italy

Cristina Antonescu United States

J. S. Lee South Korea

Sławomir Falkowski Poland

Ji Hyun Park South Korea

Mathias Hoiczyk Germany

P.D. Simmonds United Kingdom

Bart Rikhof Netherlands

A. Le Cesne

227 ×1.2

PRM

114 ×0.6

ONCOL

80 ×0.8

GASTR

76 ×1.0

38 ×0.7

SURGE

Citations per year, relative to A. Le Cesne A. Le Cesne (= 1×) peers Bart Rikhof

Countries citing papers authored by A. Le Cesne

Since Specialization

Citations

This map shows the geographic impact of A. Le Cesne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Le Cesne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Le Cesne more than expected).

Fields of papers citing papers by A. Le Cesne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Le Cesne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Le Cesne. The network helps show where A. Le Cesne may publish in the future.

Co-authorship network of co-authors of A. Le Cesne

This figure shows the co-authorship network connecting the top 25 collaborators of A. Le Cesne. A scholar is included among the top collaborators of A. Le Cesne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Le Cesne. A. Le Cesne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wallet, Jennifer, L. Chaigneau, Nelly Firmin, et al.. (2024). 1718O EREMISS trial: A double-blind placebo (PBO)-controlled randomised trial assessing efficacy/safety of regorafenib (REGO) as maintenance therapy after 1st line doxorubicin-based chemotherapy in advanced soft-tissue sarcoma (ASTS) patients (pts). Annals of Oncology. 35. S1030–S1030. 1 indexed citations

Reich, M., Juliane Berchoud, Myriam Jean‐Denis, et al.. (2023). 1971P Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study. Annals of Oncology. 34. S1053–S1053.

Grinda, Thomas, Sarah Winter, Perry Gerard, et al.. (2023). 1968P Metastatic Ewing sarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study. Annals of Oncology. 34. S1051–S1052. 1 indexed citations

Chen, Tom Wei‐Wu, A. Le Cesne, Antoîne Italiano, et al.. (2022). Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan. Cancer. 128(18). 3360–3369. 3 indexed citations

Blay, Jean‐Yves, Antoine Italiano, Nicolas Penel, et al.. (2022). 1316O Improved nationwide survival of sarcoma patients 10 years after establishment of the NETSARC+ reference center network. Annals of Oncology. 33. S1145–S1146. 2 indexed citations

Lesluyes, Tom, Christine Ménétrier‐Caux, Mehdi Brahmi, et al.. (2020). Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma. OncoImmunology. 9(1). 1792036–1792036. 30 indexed citations

Blay, Jean‐Yves, A. Le Cesne, Nicolas Penel, et al.. (2016). The nationwide cohort of 26,883 patients with sarcomas treated in NETSARC reference network between 2010 and 2015 in France: major impact of multidisciplinary board presentation prior to 1st treatment. Annals of Oncology. 27. vi483–vi483. 8 indexed citations

Penel, Nicolas, Jean‐Michel Coindre, A. Le Cesne, et al.. (2015). 3400 Management of Desmoid Tumours (DT): A nationwide survey after labeling of 2 expert networks (RRePS and NetSarc). European Journal of Cancer. 51. S688–S688. 1 indexed citations

Blay, Jean‐Yves, Julien Dômont, Claire Cropet, et al.. (2014). A Randomized Multicentre Phase Ii Study of Pazopanib Plus Best Supportive Care (Bsc) Vs Bsc Alone in Metastatic Gastrointestinal Stromal Tumors (Gist) Resistant to Imatinib and Sunitinib. Annals of Oncology. 25. v1–v1. 1 indexed citations

10.

Ray‐Coquard, Isabelle, Sophie Dussart, Didier Mayeur, et al.. (2009). A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group. Annals of Oncology. 20(6). 1105–1112. 18 indexed citations

11.

Castellazzi, Gloria, D. Vanel, A. Le Cesne, et al.. (2008). Can the MRI signal of aggressive fibromatosis be used to predict its behavior?. European Journal of Radiology. 69(2). 222–229. 40 indexed citations

12.

Pérol, David, Julien Dômont, I. L. Ray-Coquard, et al.. (2008). Does interruption of imatinib (IM) in responding GIST patients after one year of treatment influence the secondary resistance to IM after its reintroduction? Updated results of the prospective French Sarcoma Group randomized phase III trial on long term survival. Journal of Clinical Oncology. 26(15_suppl). 10556–10556. 2 indexed citations

13.

Vanel, D., Sylvie Bonvalot, C. Le Péchoux, et al.. (2007). Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases. Skeletal Radiology. 36(9). 895–898. 7 indexed citations

14.

Bui, B., et al.. (2007). Preliminary efficacy and safety results of masitinib administered, front line in patients with advanced GIST. A phase II study. Journal of Clinical Oncology. 25(18_suppl). 10025–10025. 14 indexed citations

15.

Cesne, A. Le, M. van Glabbeke, Jaap Verweij, et al.. (2006). Is a stable disease according to RECIST criteria a real stable disease in GIST patients treated with imatinib mesylate (IM) included in the intergroup EORTC/ISG/AGITG trial?. Journal of Clinical Oncology. 24(18_suppl). 9510–9510. 11 indexed citations

16.

Vanel, D., A. Le Cesne, Sylvie Bonvalot, et al.. (2005). Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. Clinical Imaging. 29(6). 446–446. 4 indexed citations

17.

Lassau, Nathalie, Michele Lamuraglia, J. Leclère, et al.. (2004). Doppler-Ultrasonography with perfusion software and contrast medium injection as an early evaluation tool of gastro intestinal stromal tumor (GIST) treated by imatinib: Results of a prospective study. Journal of Clinical Oncology. 22(14_suppl). 9048–9048. 3 indexed citations

18.

Cesne, A. Le. (2002). C-kit et GIST : rationnel de l'utilisation du Glivec dans les tumeurs stromales digestives. Annales de Pathologie. 1 indexed citations

19.

Zelek, Laurent, M. Riofrio, Karim Fizazi, et al.. (2001). Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer. 92(9). 2267–2272. 122 indexed citations

20.

Hasbini, Ali, Éric Lartigau, C. Le Péchoux, et al.. (1998). Les chondrosarcomes sur maladie d'Ollier. À propos de deux cas et revue de la littérature. Cancer/Radiothérapie. 2(4). 387–391. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact